Justilien V, Fields A P
Department of Cancer Biology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Oncogene. 2009 Oct 15;28(41):3597-607. doi: 10.1038/onc.2009.217. Epub 2009 Jul 20.
Protein kinase Ciota (PKCiota) promotes non-small cell lung cancer (NSCLC) by binding to Par6alpha and activating a Rac1-Pak-Mek1,2-Erk1,2 signaling cascade. The mechanism by which the PKCiota-Par6alpha complex regulates Rac1 is unknown. Here we show that epithelial cell transforming sequence 2 (Ect2), a guanine nucleotide exchange factor for Rho family GTPases, is coordinately amplified and overexpressed with PKCiota in NSCLC tumors. RNA interference-mediated knockdown of Ect2 inhibits Rac1 activity and blocks transformed growth, invasion and tumorigenicity of NSCLC cells. Expression of constitutively active Rac1 (RacV12) restores transformation to Ect2-deficient cells. Interestingly, the role of Ect2 in transformation is distinct from its well-established role in cytokinesis. In NSCLC cells, Ect2 is mislocalized to the cytoplasm where it binds the PKCiota-Par6alpha complex. RNA interference-mediated knockdown of either PKCiota or Par6alpha causes Ect2 to redistribute to the nucleus, indicating that the PKCiota-Par6alpha complex regulates the cytoplasmic localization of Ect2. Our data indicate that Ect2 and PKCiota are genetically and functionally linked in NSCLC, acting to coordinately drive tumor cell proliferation and invasion through formation of an oncogenic PKCiota-Par6alpha-Ect2 complex.
蛋白激酶ι(PKCι)通过与Par6α结合并激活Rac1-Pak-Mek1,2-Erk1,2信号级联反应来促进非小细胞肺癌(NSCLC)的发生发展。PKCι-Par6α复合物调节Rac1的机制尚不清楚。在此,我们发现鸟嘌呤核苷酸交换因子Ect2,一种Rho家族GTP酶的鸟嘌呤核苷酸交换因子,在NSCLC肿瘤中与PKCι协同扩增并过表达。RNA干扰介导的Ect2敲低抑制Rac1活性,并阻断NSCLC细胞的转化生长、侵袭和致瘤性。组成型活性Rac1(RacV12)的表达可恢复Ect2缺陷细胞的转化。有趣的是,Ect2在转化中的作用与其在胞质分裂中已确立的作用不同。在NSCLC细胞中,Ect2错误定位于细胞质中,在那里它与PKCι-Par6α复合物结合。RNA干扰介导的PKCι或Par6α敲低导致Ect2重新分布到细胞核,表明PKCι-Par6α复合物调节Ect2的细胞质定位。我们的数据表明,Ect2和PKCι在NSCLC中存在遗传和功能联系,通过形成致癌的PKCι-Par6α-Ect2复合物协同驱动肿瘤细胞增殖和侵袭。